Clinical Trials in Philadelphia

Showing 11501-11520 of 17,926 trials

Stress Management for High Blood Pressure

NCT02371317

The purpose of this research study is to examine the efficacy of two stress management interventions in reducing blood pressure (BP) in patients who have prehypertension (BP between 120/80 and 139/89). It is expected that participants will be better able to control their BP through reducing stress and increasing healthy lifestyle behaviors.

Prehypertension

Kent State University141 participantsStarted May 2015

Cleveland, Ohio, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 1/2< 1 mile

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

NCT01676831

The objective of this study is to explore the safety and the preliminary efficacy of two concentrations (0.06% and 0.03%)gel that is applied to lesions of early stage (IA, IB,IIA) Cutaneous T Cell Lymphoma patients. This study is supported by grant 1R01FD004092-01A1 from the Office of Orphan Products Development, FDA.

Cutaneous T Cell Lymphoma

Abramson Cancer Center at Penn Medicine13 participantsStarted Feb 2012

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Radiation Therapy in Treating Young Patients With Gliomas

NCT00238264

RATIONALE: Specialized radiation therapy that delivers radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well radiation therapy works in treating young patients with gliomas.

Brain TumorCentral Nervous System Tumor

Children's Oncology Group92 participantsStarted Nov 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +142 more locations

Stress Management for High Blood Pressure

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

Radiation Therapy in Treating Young Patients With Gliomas

Find Trials by Condition in Philadelphia

Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma

Intraoperative Imaging of Pituitary Adenomas by OTL

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma

The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia

A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)

Post-Market Clinical Follow-Up to Access & Visualize the Anus, Rectum, & Distal Colon During Transanal Procedures

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

Parent-Adolescent Interactions and Adolescent Development

LOIS: Long-Term Follow-Up in INSITE/SIFI

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab